Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT00138385Phase 4Completed
A Phase 4 trial of live attenuated influenza vaccine, Fluzone Trivalent in influenza, sponsored by National Institute of Allergy and Infectious Diseases. Started Aug 2005; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT00138385.